Darren Benjamin Orbach, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vein of Galen Malformations | 12 | 2024 | 58 | 5.660 |
Why?
|
Embolization, Therapeutic | 22 | 2023 | 1418 | 4.300 |
Why?
|
Intracranial Arteriovenous Malformations | 11 | 2020 | 366 | 2.430 |
Why?
|
Arteriovenous Fistula | 7 | 2017 | 319 | 2.340 |
Why?
|
Cerebral Angiography | 14 | 2023 | 1281 | 2.200 |
Why?
|
Central Nervous System Vascular Malformations | 6 | 2017 | 140 | 2.000 |
Why?
|
Vascular Malformations | 6 | 2023 | 468 | 1.980 |
Why?
|
Arteriovenous Malformations | 8 | 2014 | 396 | 1.380 |
Why?
|
Cranial Sinuses | 3 | 2017 | 68 | 1.370 |
Why?
|
Cerebral Veins | 3 | 2024 | 157 | 1.090 |
Why?
|
Polyvinyls | 5 | 2014 | 154 | 0.950 |
Why?
|
Moyamoya Disease | 6 | 2023 | 265 | 0.930 |
Why?
|
Cerebrovascular Disorders | 5 | 2024 | 1474 | 0.890 |
Why?
|
Sinus Pericranii | 2 | 2020 | 4 | 0.830 |
Why?
|
Thrombectomy | 3 | 2022 | 705 | 0.780 |
Why?
|
Dimethyl Sulfoxide | 3 | 2011 | 251 | 0.740 |
Why?
|
Brain Ischemia | 5 | 2023 | 3049 | 0.740 |
Why?
|
Hydrocephalus | 4 | 2023 | 764 | 0.720 |
Why?
|
Magnetic Resonance Angiography | 7 | 2024 | 1432 | 0.710 |
Why?
|
Tantalum | 2 | 2011 | 54 | 0.700 |
Why?
|
Retinal Neoplasms | 4 | 2015 | 146 | 0.700 |
Why?
|
Intracranial Aneurysm | 3 | 2018 | 1285 | 0.690 |
Why?
|
Endovascular Procedures | 8 | 2022 | 2183 | 0.680 |
Why?
|
Retinoblastoma | 4 | 2015 | 317 | 0.670 |
Why?
|
Ultrasonography, Prenatal | 2 | 2017 | 1755 | 0.660 |
Why?
|
Basilar Artery | 2 | 2017 | 205 | 0.650 |
Why?
|
Cerebral Revascularization | 4 | 2023 | 259 | 0.650 |
Why?
|
Radiology, Interventional | 3 | 2023 | 476 | 0.640 |
Why?
|
Magnetic Resonance Imaging | 23 | 2024 | 36426 | 0.640 |
Why?
|
Sclerotherapy | 3 | 2019 | 182 | 0.630 |
Why?
|
Neurocutaneous Syndromes | 3 | 2019 | 53 | 0.590 |
Why?
|
Vascular Diseases | 2 | 2023 | 1161 | 0.590 |
Why?
|
Ventriculostomy | 1 | 2019 | 131 | 0.580 |
Why?
|
Myxoma | 1 | 2018 | 114 | 0.570 |
Why?
|
Vertebral Artery | 2 | 2015 | 185 | 0.550 |
Why?
|
Intracranial Hypertension | 1 | 2019 | 193 | 0.540 |
Why?
|
Stroke | 9 | 2023 | 9757 | 0.530 |
Why?
|
Radiation Dosage | 2 | 2015 | 1958 | 0.520 |
Why?
|
Child | 49 | 2024 | 80153 | 0.520 |
Why?
|
Infant | 31 | 2024 | 36192 | 0.520 |
Why?
|
Hemangioma | 3 | 2013 | 727 | 0.510 |
Why?
|
Melphalan | 2 | 2014 | 420 | 0.510 |
Why?
|
Hyperthermia, Induced | 2 | 2009 | 417 | 0.500 |
Why?
|
Echoencephalography | 1 | 2015 | 134 | 0.490 |
Why?
|
Pia Mater | 3 | 2012 | 87 | 0.490 |
Why?
|
Disease Management | 2 | 2017 | 2508 | 0.480 |
Why?
|
Blue Toe Syndrome | 1 | 2014 | 4 | 0.480 |
Why?
|
Child, Preschool | 29 | 2024 | 42230 | 0.470 |
Why?
|
Infant, Newborn | 18 | 2024 | 26198 | 0.470 |
Why?
|
Cerebrovascular Circulation | 1 | 2024 | 2727 | 0.460 |
Why?
|
Epidural Space | 1 | 2015 | 122 | 0.460 |
Why?
|
Head | 3 | 2021 | 924 | 0.460 |
Why?
|
Spinal Cord | 3 | 2011 | 1818 | 0.450 |
Why?
|
Bradycardia | 2 | 2015 | 299 | 0.440 |
Why?
|
Antineoplastic Agents, Alkylating | 2 | 2014 | 617 | 0.430 |
Why?
|
Head Movements | 2 | 2011 | 152 | 0.430 |
Why?
|
Electroencephalography | 6 | 2017 | 6225 | 0.420 |
Why?
|
p120 GTPase Activating Protein | 2 | 2023 | 36 | 0.400 |
Why?
|
Radiography, Interventional | 3 | 2015 | 1121 | 0.400 |
Why?
|
Stents | 3 | 2016 | 3179 | 0.400 |
Why?
|
Neck | 2 | 2021 | 734 | 0.400 |
Why?
|
Brain Stem | 1 | 2017 | 858 | 0.390 |
Why?
|
Myofibromatosis | 1 | 2011 | 27 | 0.380 |
Why?
|
Surgery, Computer-Assisted | 2 | 2009 | 1007 | 0.370 |
Why?
|
Sinus Thrombosis, Intracranial | 2 | 2023 | 110 | 0.370 |
Why?
|
Angiofibroma | 1 | 2011 | 55 | 0.360 |
Why?
|
Catheterization, Peripheral | 1 | 2014 | 343 | 0.360 |
Why?
|
Echo-Planar Imaging | 2 | 2013 | 663 | 0.350 |
Why?
|
Epilepsies, Partial | 3 | 2010 | 431 | 0.350 |
Why?
|
Humans | 94 | 2024 | 761504 | 0.340 |
Why?
|
Angiography | 4 | 2021 | 1595 | 0.340 |
Why?
|
Eye Abnormalities | 3 | 2019 | 242 | 0.330 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2013 | 549 | 0.330 |
Why?
|
Fluoroscopy | 1 | 2013 | 947 | 0.330 |
Why?
|
Reflex | 1 | 2011 | 376 | 0.320 |
Why?
|
Catheterization | 4 | 2022 | 1428 | 0.320 |
Why?
|
Hospitals, Pediatric | 2 | 2017 | 1860 | 0.320 |
Why?
|
Neovascularization, Pathologic | 2 | 2009 | 2645 | 0.310 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2011 | 290 | 0.310 |
Why?
|
Epidural Neoplasms | 1 | 2008 | 24 | 0.310 |
Why?
|
Hemostatics | 1 | 2011 | 241 | 0.310 |
Why?
|
Thrombosis | 1 | 2022 | 2942 | 0.300 |
Why?
|
Spine | 2 | 2015 | 1118 | 0.300 |
Why?
|
Vertebral Artery Dissection | 1 | 2008 | 51 | 0.300 |
Why?
|
Radiography | 7 | 2015 | 6965 | 0.290 |
Why?
|
Male | 52 | 2024 | 360804 | 0.280 |
Why?
|
Genes, Dominant | 1 | 2009 | 852 | 0.280 |
Why?
|
Foreign Bodies | 1 | 2011 | 402 | 0.280 |
Why?
|
Skull Base | 1 | 2009 | 292 | 0.260 |
Why?
|
Image Enhancement | 4 | 2015 | 2885 | 0.260 |
Why?
|
Female | 49 | 2024 | 392644 | 0.260 |
Why?
|
Brain | 6 | 2024 | 27112 | 0.250 |
Why?
|
Aortic Coarctation | 2 | 2019 | 275 | 0.250 |
Why?
|
Cerebral Hemorrhage | 2 | 2015 | 2656 | 0.230 |
Why?
|
Retrospective Studies | 27 | 2023 | 80636 | 0.230 |
Why?
|
Papilloma, Choroid Plexus | 1 | 2023 | 9 | 0.230 |
Why?
|
Choroid Plexus Neoplasms | 1 | 2023 | 38 | 0.220 |
Why?
|
Microsurgery | 3 | 2015 | 795 | 0.220 |
Why?
|
Thrombolytic Therapy | 1 | 2012 | 2064 | 0.220 |
Why?
|
Abnormalities, Multiple | 1 | 2011 | 1423 | 0.220 |
Why?
|
Adolescent | 23 | 2024 | 88319 | 0.210 |
Why?
|
Chromosome Aberrations | 1 | 2009 | 1768 | 0.210 |
Why?
|
Receptor, EphB4 | 2 | 2020 | 39 | 0.210 |
Why?
|
Mastoiditis | 1 | 2023 | 37 | 0.210 |
Why?
|
Parotid Neoplasms | 1 | 2004 | 157 | 0.210 |
Why?
|
Vascular Neoplasms | 1 | 2004 | 166 | 0.210 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2013 | 3357 | 0.200 |
Why?
|
Artifacts | 1 | 2011 | 1911 | 0.200 |
Why?
|
Spinal Neoplasms | 1 | 2009 | 716 | 0.200 |
Why?
|
Preoperative Care | 1 | 2011 | 2242 | 0.200 |
Why?
|
Brain Neoplasms | 3 | 2015 | 9031 | 0.200 |
Why?
|
Punctures | 1 | 2023 | 366 | 0.200 |
Why?
|
Meningeal Neoplasms | 2 | 2021 | 1248 | 0.200 |
Why?
|
Umbilical Arteries | 1 | 2022 | 79 | 0.200 |
Why?
|
Head and Neck Neoplasms | 2 | 2017 | 2895 | 0.190 |
Why?
|
Ethics Committees, Research | 1 | 2023 | 196 | 0.190 |
Why?
|
DNA Mutational Analysis | 1 | 2009 | 4111 | 0.190 |
Why?
|
Muscle Weakness | 1 | 2004 | 412 | 0.190 |
Why?
|
Superior Sagittal Sinus | 1 | 2020 | 15 | 0.180 |
Why?
|
Blood Flow Velocity | 1 | 2024 | 1371 | 0.180 |
Why?
|
Otitis Media | 1 | 2023 | 286 | 0.180 |
Why?
|
Follow-Up Studies | 11 | 2023 | 39106 | 0.180 |
Why?
|
Ephrin-B2 | 1 | 2020 | 40 | 0.180 |
Why?
|
Phantoms, Imaging | 3 | 2017 | 2526 | 0.170 |
Why?
|
Granuloma, Pyogenic | 1 | 2020 | 47 | 0.170 |
Why?
|
Foot | 1 | 2004 | 575 | 0.170 |
Why?
|
Veins | 3 | 2023 | 768 | 0.170 |
Why?
|
Constriction, Pathologic | 1 | 2023 | 1096 | 0.170 |
Why?
|
Practice Guidelines as Topic | 3 | 2016 | 7390 | 0.170 |
Why?
|
Somatoform Disorders | 1 | 2003 | 423 | 0.170 |
Why?
|
Conversion Disorder | 1 | 2003 | 202 | 0.170 |
Why?
|
Infusions, Intra-Arterial | 2 | 2021 | 221 | 0.160 |
Why?
|
Catheters | 1 | 2022 | 427 | 0.160 |
Why?
|
Heart Failure | 1 | 2023 | 11669 | 0.160 |
Why?
|
Bone Cysts, Aneurysmal | 1 | 2019 | 70 | 0.160 |
Why?
|
Carotid Stenosis | 1 | 2006 | 860 | 0.150 |
Why?
|
Third Ventricle | 1 | 2019 | 74 | 0.150 |
Why?
|
Rhabdomyosarcoma | 1 | 2021 | 358 | 0.150 |
Why?
|
Neoplasms, Multiple Primary | 2 | 2013 | 592 | 0.150 |
Why?
|
Video Recording | 1 | 2003 | 966 | 0.140 |
Why?
|
Epilepsy | 2 | 2011 | 3290 | 0.140 |
Why?
|
Treatment Outcome | 13 | 2023 | 64680 | 0.140 |
Why?
|
Glomus Tumor | 1 | 2017 | 62 | 0.140 |
Why?
|
Pregnancy | 4 | 2023 | 29874 | 0.130 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2006 | 3769 | 0.130 |
Why?
|
Checklist | 1 | 2023 | 827 | 0.130 |
Why?
|
Polysomnography | 1 | 2003 | 1848 | 0.130 |
Why?
|
Pons | 1 | 2017 | 240 | 0.130 |
Why?
|
Reproducibility of Results | 5 | 2024 | 20098 | 0.130 |
Why?
|
Cerebellum | 2 | 2016 | 1501 | 0.130 |
Why?
|
Varicose Veins | 1 | 2017 | 155 | 0.120 |
Why?
|
Radio Waves | 1 | 2017 | 251 | 0.120 |
Why?
|
Neoplasm Seeding | 1 | 2015 | 85 | 0.120 |
Why?
|
Age Factors | 4 | 2013 | 18395 | 0.120 |
Why?
|
Ultrasonography, Interventional | 1 | 2023 | 1496 | 0.120 |
Why?
|
Fetus | 1 | 2022 | 1863 | 0.120 |
Why?
|
Diagnostic Imaging | 1 | 2009 | 3530 | 0.120 |
Why?
|
Brain Damage, Chronic | 1 | 2015 | 267 | 0.120 |
Why?
|
Electrodes | 1 | 2017 | 614 | 0.120 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2018 | 633 | 0.120 |
Why?
|
Spinal Diseases | 1 | 2019 | 564 | 0.110 |
Why?
|
Hemodynamics | 1 | 2024 | 4159 | 0.110 |
Why?
|
Ions | 1 | 2014 | 256 | 0.110 |
Why?
|
Intracranial Embolism | 1 | 2015 | 189 | 0.110 |
Why?
|
Brain Mapping | 3 | 2016 | 6630 | 0.110 |
Why?
|
Hydrodynamics | 1 | 2014 | 168 | 0.110 |
Why?
|
Materials Testing | 1 | 2017 | 863 | 0.110 |
Why?
|
Angiography, Digital Subtraction | 2 | 2023 | 335 | 0.110 |
Why?
|
Meningioma | 1 | 2021 | 1218 | 0.100 |
Why?
|
Equipment Failure | 1 | 2015 | 578 | 0.100 |
Why?
|
Intracranial Hemorrhages | 1 | 2018 | 822 | 0.100 |
Why?
|
Cohort Studies | 7 | 2021 | 41487 | 0.100 |
Why?
|
Radiology | 1 | 2006 | 2113 | 0.100 |
Why?
|
Balloon Occlusion | 1 | 2013 | 125 | 0.100 |
Why?
|
Oral Hemorrhage | 1 | 2011 | 24 | 0.100 |
Why?
|
Mouth Abnormalities | 1 | 2011 | 19 | 0.100 |
Why?
|
Hypertension, Pulmonary | 1 | 2023 | 1578 | 0.100 |
Why?
|
Lymphangioma, Cystic | 1 | 2011 | 34 | 0.100 |
Why?
|
Young Adult | 9 | 2020 | 59243 | 0.100 |
Why?
|
Registries | 2 | 2021 | 8224 | 0.100 |
Why?
|
Brain Waves | 1 | 2016 | 408 | 0.100 |
Why?
|
Skin Diseases | 1 | 2020 | 1094 | 0.100 |
Why?
|
Cerebrospinal Fluid | 1 | 2014 | 544 | 0.100 |
Why?
|
Fibrinolytic Agents | 1 | 2021 | 2084 | 0.090 |
Why?
|
Endothelial Cells | 2 | 2023 | 3548 | 0.090 |
Why?
|
Feasibility Studies | 1 | 2022 | 5247 | 0.090 |
Why?
|
Imaging, Three-Dimensional | 1 | 2024 | 4063 | 0.090 |
Why?
|
Brain Injuries | 1 | 2023 | 2053 | 0.090 |
Why?
|
Prognosis | 4 | 2021 | 29625 | 0.090 |
Why?
|
Progeria | 1 | 2012 | 188 | 0.090 |
Why?
|
Syndrome | 2 | 2021 | 3267 | 0.090 |
Why?
|
Activin Receptors, Type II | 2 | 2023 | 123 | 0.090 |
Why?
|
Hot Temperature | 1 | 2017 | 1440 | 0.090 |
Why?
|
Lymphatic Abnormalities | 1 | 2011 | 134 | 0.090 |
Why?
|
Klippel-Trenaunay-Weber Syndrome | 1 | 2010 | 69 | 0.090 |
Why?
|
Solvents | 1 | 2011 | 295 | 0.090 |
Why?
|
Ultrasonography | 1 | 2023 | 5972 | 0.080 |
Why?
|
Seizures | 1 | 2003 | 2957 | 0.080 |
Why?
|
Adult | 16 | 2023 | 221177 | 0.080 |
Why?
|
Evoked Potentials, Motor | 1 | 2013 | 464 | 0.080 |
Why?
|
Trigeminal Nerve | 1 | 2011 | 248 | 0.080 |
Why?
|
Middle Aged | 13 | 2021 | 220895 | 0.080 |
Why?
|
Hemangioma, Capillary | 1 | 2009 | 64 | 0.080 |
Why?
|
Stomatitis | 1 | 2011 | 271 | 0.080 |
Why?
|
Femoral Artery | 1 | 2013 | 826 | 0.080 |
Why?
|
Connective Tissue Diseases | 1 | 2011 | 285 | 0.080 |
Why?
|
Neurosurgical Procedures | 2 | 2020 | 2072 | 0.080 |
Why?
|
Age Distribution | 1 | 2013 | 2880 | 0.070 |
Why?
|
Spinal Cord Compression | 1 | 2009 | 235 | 0.070 |
Why?
|
Boston | 2 | 2017 | 9326 | 0.070 |
Why?
|
Retreatment | 1 | 2009 | 598 | 0.070 |
Why?
|
Clinical Trials as Topic | 1 | 2023 | 8002 | 0.070 |
Why?
|
Adenocarcinoma | 1 | 2004 | 6346 | 0.070 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2010 | 9000 | 0.070 |
Why?
|
Neurologic Examination | 1 | 2009 | 916 | 0.070 |
Why?
|
Sensitivity and Specificity | 3 | 2013 | 14666 | 0.070 |
Why?
|
Device Removal | 1 | 2011 | 630 | 0.070 |
Why?
|
Incidence | 3 | 2020 | 21353 | 0.070 |
Why?
|
Vascular Surgical Procedures | 1 | 2015 | 1489 | 0.060 |
Why?
|
Movement | 1 | 2013 | 1478 | 0.060 |
Why?
|
Motor Cortex | 1 | 2013 | 1006 | 0.060 |
Why?
|
Radiosurgery | 1 | 2015 | 1342 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 3 | 2014 | 20570 | 0.060 |
Why?
|
Diagnosis, Differential | 3 | 2020 | 12974 | 0.060 |
Why?
|
Drug Combinations | 1 | 2011 | 2048 | 0.060 |
Why?
|
Lumbar Vertebrae | 2 | 2019 | 1879 | 0.060 |
Why?
|
Mutation | 5 | 2023 | 30052 | 0.060 |
Why?
|
Positron-Emission Tomography | 1 | 2021 | 6485 | 0.060 |
Why?
|
Pediatrics | 1 | 2019 | 3589 | 0.060 |
Why?
|
Lethargy | 1 | 2023 | 43 | 0.060 |
Why?
|
Thoracic Vertebrae | 1 | 2008 | 597 | 0.050 |
Why?
|
Linear Models | 1 | 2013 | 5871 | 0.050 |
Why?
|
Developmental Disabilities | 1 | 2012 | 1509 | 0.050 |
Why?
|
Hemorrhage | 1 | 2015 | 3424 | 0.050 |
Why?
|
Angioplasty | 1 | 2006 | 355 | 0.050 |
Why?
|
Oxygen | 1 | 2014 | 4227 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3084 | 0.050 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2023 | 2790 | 0.050 |
Why?
|
Alpha Rhythm | 1 | 2003 | 110 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3204 | 0.050 |
Why?
|
Skin Neoplasms | 2 | 2013 | 5821 | 0.050 |
Why?
|
Combined Modality Therapy | 2 | 2015 | 8529 | 0.050 |
Why?
|
Cervical Vertebrae | 1 | 2008 | 980 | 0.050 |
Why?
|
Statistics as Topic | 1 | 2008 | 2358 | 0.050 |
Why?
|
Models, Theoretical | 1 | 2013 | 3575 | 0.050 |
Why?
|
Epilepsy, Temporal Lobe | 1 | 2005 | 389 | 0.050 |
Why?
|
Algorithms | 2 | 2013 | 14031 | 0.050 |
Why?
|
Receptors, Calcitonin Gene-Related Peptide | 1 | 2020 | 31 | 0.040 |
Why?
|
Mass Screening | 1 | 2016 | 5428 | 0.040 |
Why?
|
GTPase-Activating Proteins | 1 | 2023 | 471 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8654 | 0.040 |
Why?
|
Prospective Studies | 1 | 2024 | 54425 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11742 | 0.040 |
Why?
|
Blood Loss, Surgical | 1 | 2023 | 637 | 0.040 |
Why?
|
Ephrins | 1 | 2018 | 28 | 0.040 |
Why?
|
Cerebral Infarction | 1 | 2023 | 983 | 0.040 |
Why?
|
Catheter Ablation | 1 | 2011 | 2751 | 0.040 |
Why?
|
Postoperative Complications | 4 | 2023 | 15631 | 0.040 |
Why?
|
Corpus Callosum | 1 | 2003 | 751 | 0.040 |
Why?
|
Risk Assessment | 3 | 2016 | 23995 | 0.040 |
Why?
|
Aged | 4 | 2016 | 169289 | 0.040 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2021 | 899 | 0.040 |
Why?
|
Doxycycline | 1 | 2019 | 344 | 0.040 |
Why?
|
Penetrance | 1 | 2018 | 383 | 0.030 |
Why?
|
Metalloendopeptidases | 1 | 2018 | 393 | 0.030 |
Why?
|
Arousal | 1 | 2003 | 1166 | 0.030 |
Why?
|
Hematoma | 1 | 2021 | 768 | 0.030 |
Why?
|
Cerebral Arteries | 1 | 2019 | 490 | 0.030 |
Why?
|
Turtles | 1 | 2016 | 40 | 0.030 |
Why?
|
Cell Adhesion Molecules | 1 | 2021 | 1600 | 0.030 |
Why?
|
Genes, ras | 1 | 2018 | 654 | 0.030 |
Why?
|
Neuropsychological Tests | 2 | 2005 | 7045 | 0.030 |
Why?
|
Genotype | 1 | 2009 | 12990 | 0.030 |
Why?
|
Cyclophosphamide | 1 | 2021 | 2218 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2010 | 22176 | 0.030 |
Why?
|
Genes, Retinoblastoma | 1 | 2015 | 125 | 0.030 |
Why?
|
United States | 1 | 2023 | 72334 | 0.030 |
Why?
|
Mutation, Missense | 1 | 2023 | 2571 | 0.030 |
Why?
|
Ophthalmic Artery | 1 | 2014 | 58 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3305 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2018 | 15266 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2023 | 2135 | 0.030 |
Why?
|
Electrophysiological Phenomena | 1 | 2016 | 307 | 0.030 |
Why?
|
Sirolimus | 1 | 2021 | 1533 | 0.030 |
Why?
|
Injections, Intra-Arterial | 1 | 2013 | 182 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2020 | 0.030 |
Why?
|
Dominance, Cerebral | 2 | 2005 | 623 | 0.030 |
Why?
|
Anti-Bacterial Agents | 2 | 2023 | 7407 | 0.030 |
Why?
|
Animals | 4 | 2023 | 168459 | 0.030 |
Why?
|
Diffusion Tensor Imaging | 1 | 2023 | 2400 | 0.030 |
Why?
|
Headache | 1 | 2020 | 1256 | 0.030 |
Why?
|
ROC Curve | 1 | 2020 | 3579 | 0.020 |
Why?
|
Joint Instability | 1 | 2019 | 801 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2014 | 13639 | 0.020 |
Why?
|
Pedigree | 1 | 2018 | 4542 | 0.020 |
Why?
|
Electric Stimulation | 1 | 2016 | 1736 | 0.020 |
Why?
|
Eye | 1 | 2013 | 712 | 0.020 |
Why?
|
Risk Factors | 2 | 2013 | 74206 | 0.020 |
Why?
|
Forecasting | 1 | 2018 | 2928 | 0.020 |
Why?
|
Recurrence | 1 | 2021 | 8465 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2016 | 1496 | 0.020 |
Why?
|
Signal Transduction | 2 | 2023 | 23445 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2018 | 3702 | 0.020 |
Why?
|
Computer Simulation | 1 | 2021 | 6240 | 0.020 |
Why?
|
Migraine Disorders | 1 | 2020 | 1701 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2019 | 15842 | 0.020 |
Why?
|
Anticoagulants | 1 | 2023 | 4812 | 0.020 |
Why?
|
Gene Expression | 1 | 2020 | 7581 | 0.020 |
Why?
|
Cerebral Cortex | 1 | 2003 | 5777 | 0.020 |
Why?
|
Consensus | 1 | 2016 | 3123 | 0.020 |
Why?
|
Genetic Variation | 1 | 2021 | 6567 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2011 | 1475 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2020 | 12795 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2020 | 18965 | 0.010 |
Why?
|
Pain | 1 | 2019 | 5073 | 0.010 |
Why?
|
Phenotype | 1 | 2021 | 16591 | 0.010 |
Why?
|
Transcription Factors | 1 | 2021 | 12128 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2018 | 14605 | 0.010 |
Why?
|
Physicians | 1 | 2019 | 4591 | 0.010 |
Why?
|
Reoperation | 1 | 2011 | 4303 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2006 | 58976 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2015 | 11121 | 0.010 |
Why?
|
Temporal Lobe | 1 | 2005 | 1695 | 0.010 |
Why?
|
Mice | 1 | 2023 | 81525 | 0.010 |
Why?
|
Comorbidity | 1 | 2010 | 10508 | 0.010 |
Why?
|
Memory | 1 | 2005 | 2188 | 0.010 |
Why?
|
Hippocampus | 1 | 2005 | 3766 | 0.010 |
Why?
|